RFK Jr. Claims 'Everybody Can Get' a COVID-19 Vaccine: Fact-Check

RFK Jr. asserts that 'everybody can get' the COVID-19 vaccine, but the reality involves regulatory, logistical, and coverage barriers that limit access for many. Read our fact-checking analysis.
During a Senate Finance Committee hearing on September 4, Robert F. Kennedy Jr. stated that 'everybody can get' the COVID-19 vaccine. However, this assertion requires context. While Kennedy emphasized that vaccines are technically accessible to all, the current public health guidelines and regulations have placed restrictions on who can receive the latest COVID-19 boosters. On August 27, the FDA updated its guidance, authorizing the vaccine for specific groups, notably those 65 years and older and individuals aged six months and above with underlying health conditions that increase their risk of severe COVID-19. Kennedy responded to criticisms by asserting that 'anybody can get the booster,' but clarified that it’s not recommended for healthy individuals. This statement overlooks the fact that vaccine availability is influenced by state regulations, prescription requirements, and insurance coverage, which vary significantly. For example, in some states, individuals need a doctor's prescription to get vaccinated, which could involve out-of-pocket costs and limited access at pharmacies. Moreover, the CDC’s Advisory Committee on Immunization Practices (ACIP), which guides vaccine recommendations, has yet to issue new guidance for the updated COVID vaccines. Until such guidance is provided, vaccine distribution and coverage remain uncertain. Kennedy’s broad claim that 'everybody can get it' simplifies the complex regulatory and logistical landscape, potentially misleading the public about the true accessibility of COVID-19 vaccines in the current phase of the pandemic. Source: https://medicalxpress.com/news/2025-09-rfk-jr-covid-vaccine-true.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Understanding the Lifelong Roots of Dementia and the Importance of Prevention from Childhood
Emerging research highlights the importance of early-life and childhood factors in the development of dementia, emphasizing lifelong prevention for healthier aging.
Star-Shaped Brain Cells Offer New Hope for Personalized Bipolar Disorder Treatment
Research uncovers metabolic differences in astrocytes based on lithium response, paving the way for personalized bipolar disorder treatments.
Innovative Portable Device Enables Real-Time Monitoring of Alzheimer's Disease Progression
A new portable microfluidic device provides real-time, label-free monitoring of microglia response to amyloid beta oligomers, offering a promising tool for Alzheimer's disease research and diagnostics.
Innovative Gene Therapy Shows Promise in Slowing Motor Decline in ALS Patients
New gene therapy approaches targeting TDP-43 and ATXN2 proteins show promise in slowing motor decline in ALS, offering hope for more effective treatments.



